Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy

The goal of this study was to explore the relationship of the BRAFV600E mutation with clinicopathologic factors and evaluate the effect of radioactive iodine (RAI) therapy in a large group of intermediate- and high-risk papillary thyroid cancer (PTC) patients with the BRAFV600E mutation and without...

Full description

Bibliographic Details
Main Authors: Guoquan Zhu, Yuying Deng, Liqin Pan, Wei Ouyang, Huijuan Feng, Juqing Wu, Pan Chen, Jing Wang, Yanying Chen, Jiaxin Luo
Format: Article
Language:English
Published: Bioscientifica 2019-05-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/8/6/EC-19-0045.xml